tiprankstipranks
Zyversa Therapeutics, Inc. (ZVSA)
:ZVSA
US Market
Holding ZVSA?
Track your performance easily

ZyVersa Therapeutics (ZVSA) Financial Statements

169 Followers

ZyVersa Therapeutics Financial Overview

ZyVersa Therapeutics's market cap is currently ―. The company's EPS TTM is $-43.19; its P/E ratio is ―; ZyVersa Therapeutics is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.27M$ -2.75M$ 2.83M$ -1.78M$ -2.90M
EBITDA$ -2.27M$ -2.75M$ 2.83M$ -1.77M$ -2.90M
Net Income Common Stockholders$ -2.40M$ -2.76M$ -2.80M$ -13.34M$ -2.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.92K$ 119.49K$ 2.03M$ 3.14M$ 1.58M
Total Assets$ 19.42M$ 19.47M$ 21.65M$ 22.11M$ 32.85M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 12.40M$ 10.85M$ 10.43M$ 11.04M$ 13.15M
Stockholders Equity$ 7.03M$ 8.62M$ 11.22M$ 11.07M$ 19.70M
Cash Flow-
Free Cash Flow$ -600.00K$ -1.90M$ -3.80M$ -2.79M$ -936.39K
Operating Cash Flow$ -600.00K$ -1.90M$ -3.80M$ -2.79M$ -936.39K
Investing Cash Flow-----
Financing Cash Flow$ 647.84K-$ 2.67M$ 4.35M$ 2.29M
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History

ZyVersa Therapeutics Debt to Assets

ZyVersa Therapeutics Cash Flow

ZyVersa Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis